[Thalidomide in combination with interferon and interleukin 2 in the induction therapy for relapsed refractory acute myeloid leukemia: two case report and literature review]

Zhonghua Xue Ye Xue Za Zhi. 2014 Oct;35(10):954-6. doi: 10.3760/cma.j.issn.0253-2727.2014.10.019.

[Article in Chinese]

Authors

Hao Ai¹, Yanli Zhang¹, Xudong Wei¹, Qingsong Yin¹, Ping Wang¹, Ruihua Mi¹, Yongping Song¹

Affiliation

¹ Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.

PMID: 25339339
DOI: 10.3760/cma.j.issn.0253-2727.2014.10.019

No abstract available

Publication types

Case Reports
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Interferons / administration & dosage
Interleukin-2 / administration & dosage
Leukemia, Myeloid, Acute / drug therapy*
Recurrence
Thalidomide / administration & dosage

Substances

Interleukin-2
Thalidomide
Interferons